+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Injectable Drug Delivery to 2024

  • ID: 4700781
  • Report
  • November 2018
  • Region: Global
  • Greystone Associates
1 of 3

The correlation between chronic conditions and the benefits of patient self-administration continues to influence therapeutic product decisions, managed care initiatives and regulatory actions. Drug injection device designs are increasingly being based on the results of human engineering inputs and patient preference research. Branding and packaging choices are more frequently being driven by data sources historically employed by consumer product marketers. For drug developers and device suppliers, the implications of these trends are influencing product development methodology and changing supply chain relationships. Decisions regarding as-supplied packaging that were once considered boilerplate have moved to the early stages of the development process. The trend toward self-administration of injectables will exert increasing influence on all aspects of the parenteral drug sector.

Injectable Drug Delivery to 2024 – What You Will Learn

  • What are the dynamics of the shifting landscape for injectable drug delivery and the market impact of new and evolving syringes and injectors by therapeutic indication?
  • What are the market drivers influencing syringes and injectors – device designs, feature/functionality, product branding, competing technologies and commercial development?
  • What are the key characteristics of the major injectable device market segments and what is the impact of market demographics, and competing business strategies?
  • What is the current market demand for syringes and injectors by indication and therapy and what will it be in 2024?
  • Who are the leading injection device companies, and what are their product development activities, business strategies, and corporate alliances and affiliations?
  • What is the impact of economic, technology, and regulatory factors on injectable drug delivery demand?
Note: Product cover images may vary from those shown
2 of 3

1. Executive Summary

2. Injectable Drug Market Dynamics

  • Evolution in Drug Development
  • Injectables Demand Drivers
  • Diseases and Indications
  • Population Demographics
  • Competitive landscape
  • Risks & Opportunities
  • Technology Risks
  • Market Risks
  • Regulatory Risks

3. Device Design & Selection Factors

  • Market Segmentation
  • Product Features & Ease of Use
  • Supply Chain Factors
  • Capabilities & Market Presence
  • Regional Market Factors
  • Design Requirements
  • Design Ergonomics
  • Ease-of-Use
  • Patient Safety
  • Dosing Frequency
  • Drug Stability & Shelf Life
  • Drug Reconstitution
  • Fixed vs Variable Dose Devices

4. Competing Injection Device Classes

  • Prefilled Syringes (PFS)
  • Glass PFS
  • Plastic PFS
  • Autoinjectors
  • Standard PFS Compatible
  • Custom Design
  • Reusable vs Disposable Designs
  • Dual Chamber Syringes
  • Needle-free Injectors (NFI)
  • Prefilled NFI
  • Reusable vs Disposable Designs
  • Pen Injectors
  • Branded Custom Pens
  • OEM Devices

5. Patch Pumps

  • Mechanical vs Electronic
  • Disposable vs Reusable
  • Prefilled vs Patient Fillable
  • Subcutaneous Infusion Devices
  • Mechanical vs Electronic
  • Disposable vs Reusable
  • Volume/Viscosity Capabilities
  • Patient Interface
  • Injection Methodology
  • Primary Container
  • Duration Dependent Dosing
  • Device Segmentation
  • OEM Devices
  • Captive Devices
  • Product Specific Devices

6. Trending Specialty Injectable

  • Device Capabilities
  • Communication-enabled Devices
  • High Viscosity Capable Devices
  • Large Volume Wearable Devices
  • Drug Injection Device Market Segment Analysis & Forecasts
  • Anticoagulants
  • Antivirals
  • Autoimmune Diseases
  • Diabetes
  • Emergency Medicine
  • Hematopoietics
  • Hormone Replacement
  • Neurology
  • Osteoporosis
  • Reproductive Health
  • Vaccines

7. Market Factors

  • Regulatory Issues
  • Device Branding
  • Patient Compliance
  • Healthcare Economics
  • Partnerships and Alliances

8. Company Profiles

Note: Product cover images may vary from those shown
3 of 3


4 of 3

Research methodology is based on primary research in the form of in-depth interviews with key market participants, technology developers, distributors, industry experts, and market influencers, a list that includes regulatory officials, industry trade groups, and materials standards organizations.

Primary data is evaluated and normalized against secondary sources including trade journal articles, technical literature, industry publications, company data sheets and published information, and statistical data from government agencies and trade associations.

Forecasts and projections of market demand and future market activity are derived using standard modeling and statistical techniques.